Derivatives of 8-substituted xanthines
US7579348B2 · kind B2 · utility
112Cited by
3References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2006 |
| Grant date | Aug 25, 2009 |
| Priority date | — |
| Expiry date | Apr 29, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds and pharmaceutical compositions that are substituted pyridyl-linked-xantbines of formula Iwhich are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.